lamotrigine has been researched along with Idiopathic Parkinson Disease in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The phenytoin treatment causes cerebellar defect and anemia." | 2.82 | The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches. ( Agrawal, M; Dhurandhar, Y; Panda, SP, 2022) |
| "The neurodegenerative disorders (Parkinson's disease, Alzheimer's dementia, Huntington's disease, cerebellar degeneration) are common medical and social problems." | 2.40 | [Neurodegeneration: aging and dementia. Etiopathogenic role of electron transport disorders. Therapeutic possibilities]. ( Klivényi, P; Vécsei, L, 1997) |
| "In rodent models of Parkinson's disease such as reserpinized or 6-hydroxydopamine substantia nigra lesioned rats, blockade of glutamate receptors of the NMDA (N-methyl-D-aspartate) or the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate) receptor subtypes and concomitant treatment with L-DOPA (L-3,4-dihydroxyphenylalanine) or direct dopamine agonists restores locomotor activity and induces rotations." | 1.29 | Lamotrigine has no antiparkinsonian activity in rat models of Parkinson's disease. ( Eblen, F; Kockgether, T; Löschmann, PA; Wachtel, H; Wüllner, U, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Panda, SP | 1 |
| Dhurandhar, Y | 1 |
| Agrawal, M | 1 |
| Marino, SE | 1 |
| Meador, KJ | 1 |
| Loring, DW | 1 |
| Okun, MS | 1 |
| Fernandez, HH | 1 |
| Fessler, AJ | 1 |
| Kustra, RP | 1 |
| Miller, JM | 1 |
| Ray, PG | 1 |
| Roy, A | 1 |
| Schoenberg, MR | 1 |
| Vahle, VJ | 1 |
| Werz, MA | 1 |
| Sabolek, M | 1 |
| Runge, U | 1 |
| Meldrum, BS | 1 |
| Zipp, F | 2 |
| Baas, H | 2 |
| Fischer, PA | 2 |
| Löschmann, PA | 1 |
| Eblen, F | 1 |
| Wüllner, U | 1 |
| Wachtel, H | 1 |
| Kockgether, T | 1 |
| Klivényi, P | 1 |
| Vécsei, L | 1 |
| Shinotoh, H | 1 |
| Vingerhoets, FJ | 1 |
| Lee, CS | 1 |
| Uitti, RJ | 1 |
| Schulzer, M | 1 |
| Calne, DB | 1 |
| Tsui, J | 1 |
| Bürklin, F | 1 |
| Stecker, K | 1 |
3 reviews available for lamotrigine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches.
Topics: Anticonvulsants; Carbamazepine; Dementia; Epilepsy; Felbamate; Gabapentin; Humans; Inflammasomes; La | 2022 |
The role of glutamate in epilepsy and other CNS disorders.
Topics: Animals; Central Nervous System Diseases; Epilepsy; Glutamic Acid; Humans; Lamotrigine; Mice; N-Meth | 1994 |
[Neurodegeneration: aging and dementia. Etiopathogenic role of electron transport disorders. Therapeutic possibilities].
Topics: Aged; Aging; Alzheimer Disease; Calcium Channel Blockers; Cerebellar Diseases; Dementia; Electron Tr | 1997 |
3 trials available for lamotrigine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Subjective perception of cognition is related to mood and not performance.
Topics: Adult; Affect; Anticonvulsants; Cognition; Cross-Over Studies; Depression; Double-Blind Method; Epil | 2009 |
Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
Topics: Adult; Anticonvulsants; Antiparkinson Agents; Carbidopa; Cross-Over Studies; Dose-Response Relations | 1997 |
Lamotrigine in Parkinson's disease--a double blind study.
Topics: Adult; Aged; Calcium Channel Blockers; Double-Blind Method; Female; Humans; Lamotrigine; Male; Middl | 1995 |
3 other studies available for lamotrigine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Lamotrigine induced dyskinesia in Parkinson's disease.
Topics: Anticonvulsants; Dopamine Agonists; Dyskinesia, Drug-Induced; Epilepsy, Temporal Lobe; Humans; Lamot | 2010 |
Lamotrigine--antiparkinsonian activity by blockade of glutamate release?
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Female; Glutamates; Glutamic Acid; Humans; Lamotrigine; | 1993 |
Lamotrigine has no antiparkinsonian activity in rat models of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Dose-Response Relationship, Drug; Lamotrigine; Male; Mot | 1995 |